Persona-Dx

Oxford Biomarkers

This company develops AI-driven precision diagnostic tests and biomarkers to help clinicians personalise cancer treatments and identify chemotherapy toxicity risks for patients.

Panakeia

The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.

MultivisionDx

This company develops AI-powered spatial biology platforms and diagnostic tests for clinicians and researchers to improve treatment decisions for solid cancer patients.

DoMore Diagnostics

This company develops artificial intelligence software for digital pathology to help oncologists and pathologists provide personalised cancer treatment paths for patients.

Spotlight Medical

This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Asylia Diagnostics

This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.